Boston Scientific (BSX)

EBITDA Growth

10.53%

Quarterly · Period ending:

BSX logo

BSX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported10.53%
BSX Quarterly EBITDA YoY % (-56.44% → 10.53%)
High-resolution chart · PNG

BSX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific EBITDA Growth — Quarterly
Period endingEBITDA Growth
-56.2791%
-30.0493%
-17.4917%
27.027%
-9.6639%
-8.5586%
162.2944%
13.8462%
105.1724%
100%
-1,360.1036%
4.4177%
-16.4265%
-1.5957%
72.3214%
14.1155%
-19.0671%
-34.4567%
-60.7018%
38.6277%
128.0585%
131.9407%
50.7937%
147.4843%
144.9511%
149.8316%
11.5044%
11.9718%
11.2319%
18.8%
26.9663%
10.9375%
18.9655%
13.6364%
127.8997%
-57.2621%
-58.4973%
-56.4356%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.